SB 527: Pharmaceutical Substance Manufacturing Grant Fund; created.

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

Pharmaceutical Substance Manufacturing Grant Fund. Establishes the Pharmaceutical Substance Manufacturing Grant Fund to provide grant installment awards between July 1, 2026, and July 1, 2045, in an amount not to exceed $34 million per fiscal year and in an aggregate amount not to exceed $191,255,000, to a qualified company that (i) engages in the manufacture of pharmaceutical substances, (ii) executes a memorandum of understanding with the Commonwealth, and (iii) is expected to make a capital investment of at least $4 billion and create and maintain at least 500 new full-time jobs. This bill is identical to HB 1076.

Sponsors

Sponsors by party (alphabetical): Democratic 1

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

1. April 13, 2026Approved by Governor-Chapter 809 (effective 7/1/2026)
2. March 10, 2026Governor's Action Deadline 11:59 p.m., April 13, 2026
3. March 10, 2026Enrolled Bill communicated to Governor on March 10, 2026
4. March 5, 2026Signed by President
5. March 5, 2026Signed by Speaker
6. March 5, 2026Fiscal Impact Statement from Department of Planning and Budget (SB527)
7. March 5, 2026Bill text as passed Senate and House (SB527ER)
8. March 5, 2026Enrolled
9. March 2, 2026Passed House (92-Y 6-N 0-A)
10. March 2, 2026Read third time
11. March 2, 2026Moved from Uncontested Calendar to Regular Calendar
12. February 27, 2026Read second time

Showing 12 most recent of 29 actions. Full history